Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:BFLY NASDAQ:LMAT NASDAQ:MDXG NASDAQ:PLSE On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBFLYButterfly Network$7.31-3.5%$5.69$1.32▼$9.69$1.93B2.0511.74 million shs5.78 million shsLMATLeMaitre Vascular$101.82-3.7%$98.19$79.00▼$118.01$2.42B0.52347,895 shs414,463 shsMDXGMiMedx Group$4.26+1.4%$3.69$3.03▼$7.99$625.57M1.451.21 million shs1.31 million shsPLSEPulse Biosciences$28.11+0.3%$25.10$12.56▼$31.00$1.94B1.65337,538 shs221,390 shs7 Stocks That Could Lead the Next Market BoomTesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBFLYButterfly Network-7.63%-9.73%+66.54%+83.02%+301.38%LMATLeMaitre Vascular+1.91%+10.15%+11.88%-5.97%+27.38%MDXGMiMedx Group+3.19%+9.09%+12.30%+5.79%-35.19%PLSEPulse Biosciences-3.71%+1.08%+10.66%+47.06%+77.29%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBFLYButterfly Network$7.31-3.5%$5.69$1.32▼$9.69$1.93B2.0511.74 million shs5.78 million shsLMATLeMaitre Vascular$101.82-3.7%$98.19$79.00▼$118.01$2.42B0.52347,895 shs414,463 shsMDXGMiMedx Group$4.26+1.4%$3.69$3.03▼$7.99$625.57M1.451.21 million shs1.31 million shsPLSEPulse Biosciences$28.11+0.3%$25.10$12.56▼$31.00$1.94B1.65337,538 shs221,390 shs7 Stocks That Could Lead the Next Market BoomTesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBFLYButterfly Network-7.63%-9.73%+66.54%+83.02%+301.38%LMATLeMaitre Vascular+1.91%+10.15%+11.88%-5.97%+27.38%MDXGMiMedx Group+3.19%+9.09%+12.30%+5.79%-35.19%PLSEPulse Biosciences-3.71%+1.08%+10.66%+47.06%+77.29%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBFLYButterfly Network 2.33Hold$5.56-23.92% DownsideLMATLeMaitre Vascular 2.50Moderate Buy$112.6010.59% UpsideMDXGMiMedx Group 2.71Moderate Buy$8.5099.53% UpsidePLSEPulse Biosciences 2.50Moderate Buy$30.679.10% UpsideCurrent Analyst Ratings BreakdownLatest MDXG, LMAT, BFLY, and PLSE Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails7/6/2026LMATLeMaitre Vascular Zacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeStrong-Buy ➝ Hold6/30/2026LMATLeMaitre Vascular Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeBuy (B) ➝ Buy (B-)6/4/2026PLSEPulse Biosciences Canaccord Genuity GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageBuy$32.006/3/2026LMATLeMaitre Vascular Barrington ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingOutperform$120.005/20/2026LMATLeMaitre Vascular Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeBuy (B-) ➝ Buy (B)5/18/2026MDXGMiMedx Group Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeSell (D+) ➝ Sell (D)5/6/2026BFLYButterfly Network Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)5/6/2026LMATLeMaitre Vascular Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeBuy (B) ➝ Buy (B-)5/6/2026LMATLeMaitre Vascular Barrington ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOutperform$105.00 ➝ $120.005/6/2026LMATLeMaitre Vascular Citizens JmpSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetMarket Outperform$118.00 ➝ $127.005/6/2026LMATLeMaitre Vascular Wells Fargo & CompanySubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetEqual Weight$94.00 ➝ $104.00(Data available from 7/8/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBFLYButterfly Network$97.61M19.07N/AN/A$0.77 per share9.49LMATLeMaitre Vascular$249.60M9.32$2.80 per share36.42$17.35 per share5.87MDXGMiMedx Group$418.63M1.52$0.56 per share7.58$1.73 per share2.46PLSEPulse Biosciences$350K5,558.55N/AN/A$1.19 per share23.62Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBFLYButterfly Network-$77.06M-$0.30N/AN/AN/A-73.63%-34.41%-23.91%7/31/2026 (Estimated)LMATLeMaitre Vascular$57.73M$2.7137.5731.142.9424.35%15.36%9.78%8/4/2026 (Estimated)MDXGMiMedx Group$48.58M$0.2021.3060.86N/A7.88%21.03%15.92%7/29/2026 (Estimated)PLSEPulse Biosciences-$72.78M-$1.10N/AN/AN/AN/A-86.67%-73.61%8/11/2026 (Estimated)Latest MDXG, LMAT, BFLY, and PLSE EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/4/2026Q2 2026LMATLeMaitre Vascular$0.81N/AN/AN/A$71.47 millionN/A7/31/2026Q2 2026BFLYButterfly Network-$0.03N/AN/AN/A$29.16 millionN/A7/29/2026Q2 2026MDXGMiMedx Group-$0.0336N/AN/AN/A$63.45 millionN/A5/5/2026Q1 2026LMATLeMaitre Vascular$0.66$0.68+$0.02$0.68$66.67 million$66.55 million5/4/2026Q1 2026PLSEPulse Biosciences-$0.32-$0.27+$0.05-$0.27$0.25 million$0.40 million4/30/2026Q1 2026BFLYButterfly Network-$0.04-$0.03+$0.01-$0.05$26.08 million$26.53 million4/29/2026Q1 2026MDXGMiMedx Group-$0.07-$0.05+$0.02-$0.07$65.80 million$58.99 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthBFLYButterfly NetworkN/AN/AN/AN/AN/ALMATLeMaitre Vascular$1.000.98%+16.05%36.90%14 YearsMDXGMiMedx GroupN/AN/AN/AN/AN/APLSEPulse BiosciencesN/AN/AN/AN/AN/ALatest MDXG, LMAT, BFLY, and PLSE DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date4/28/2026LMATLeMaitre Vascularquarterly$0.251%5/21/20265/21/20266/4/2026(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBFLYButterfly NetworkN/A4.023.03LMATLeMaitre Vascular0.4214.3212.20MDXGMiMedx Group0.075.394.81PLSEPulse BiosciencesN/A7.267.24Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBFLYButterfly Network37.85%LMATLeMaitre Vascular84.64%MDXGMiMedx Group79.15%PLSEPulse Biosciences76.95%Insider OwnershipCompanyInsider OwnershipBFLYButterfly Network21.99%LMATLeMaitre Vascular7.40%MDXGMiMedx Group2.50%PLSEPulse Biosciences74.00%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBFLYButterfly Network460254.63 million198.64 millionOptionableLMATLeMaitre Vascular49022.85 million21.16 millionOptionableMDXGMiMedx Group870148.95 million145.22 millionOptionablePLSEPulse Biosciences14069.21 million18.00 millionOptionableMDXG, LMAT, BFLY, and PLSE HeadlinesRecent News About These CompaniesDelcath Systems (NASDAQ:DCTH) and Pulse Biosciences (NASDAQ:PLSE) Head-To-Head ContrastJuly 5 at 2:14 AM | americanbankingnews.comWhat Do Pulse Biosciences’ New Equity Awards Reveal About Executive Compensation Trends?June 15, 2026 | kalkinemedia.comKWhat Could New Equity Awards Signal for Pulse Biosciences’ Ongoing Growth Efforts?June 15, 2026 | kalkinemedia.comKPulse Biosciences Shareholders Approve Board and Auditor SlateJune 12, 2026 | tipranks.comPulse Biosciences, Inc. (PLSE) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 TranscriptJune 10, 2026 | seekingalpha.comPulse Biosciences Updates 2026 Cardiac Ablation StrategyJune 10, 2026 | theglobeandmail.comPulse Bio to redeem remaining common stock warrantsJune 10, 2026 | seekingalpha.comDid New Analyst Coverage and Insider Buying Just Shift Pulse Biosciences' (PLSE) Investment Narrative?June 9, 2026 | finance.yahoo.comPulse Biosciences to Present at the Goldman Sachs 47th Annual Global Healthcare Conference 2026May 27, 2026 | businesswire.comHere's Why Pulse Biosciences, Inc (PLSE) is a Great Momentum Stock to BuyMay 26, 2026 | zacks.comWhy Pulse Biosciences, Inc.’s (PLSE) Stock Is Down 6.55%May 16, 2026 | aaii.comAPulse Biosciences, Inc. (PLSE) Presents at Bank of America Global Healthcare Conference 2026 Prepared Remarks TranscriptMay 13, 2026 | seekingalpha.comPulse Biosciences, Inc. (PLSE) Presents at Bank of America Global Healthcare Conference 2026 - SlideshowMay 13, 2026 | seekingalpha.comPulse Biosciences (NASDAQ:PLSE) CEO Acquires $295,350.00 in StockMay 12, 2026 | insidertrades.comPulse Biosciences Authorizes Insider Purchases Under Equity ProgramMay 11, 2026 | theglobeandmail.comIs Pulse Biosciences (PLSE) Quietly Redefining Its Core Identity Around Atrial Fibrillation?May 11, 2026 | finance.yahoo.comPLSE Q1 2026 Earnings TranscriptMay 8, 2026 | finance.yahoo.comPulse Biosciences to Present at the BofA Securities 2026 Healthcare ConferenceMay 8, 2026 | finance.yahoo.comPulse Biosciences, Inc. (PLSE) Q1 2026 Earnings Call TranscriptMay 8, 2026 | seekingalpha.comPulse Biosciences (PLSE) Upgraded to Buy: What Does It Mean for the Stock?May 7, 2026 | zacks.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeMDXG, LMAT, BFLY, and PLSE Company DescriptionsButterfly Network NYSE:BFLY$7.31 -0.27 (-3.55%) Closing price 03:59 PM EasternExtended Trading$7.44 +0.13 (+1.83%) As of 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Butterfly Network, Inc. develops, manufactures, and commercializes ultrasound imaging solutions in the United States and internationally. It offers Butterfly iQ, a handheld and single-probe whole body ultrasound system; Butterfly iQ+ and iQ3 ultrasound devices that can perform whole-body imaging in a single handheld probe integrated with the clinical workflow, and accessible on a user's smartphone, tablet, and almost any hospital computer system; and Butterfly iQ+ Vet, a handheld ultrasound system designed for veterinarians. The company also provides Butterfly system, which includes probes, and related accessories and software subscriptions to healthcare systems, physicians, and healthcare providers through a direct sales force, distributors, and eCommerce channel. In addition, it offers cloud-based software solutions to healthcare systems, teleguidance, in-app educational tutorials, and formal education programs through its Butterfly Academy software, as well as professional services for large scale deployments; and ScanLab, an education-only app provides written walkthroughs and reference imagery to guide real-time educational scanning, enhancing the learning process. Butterfly Network, Inc. was founded in 2011 and is headquartered in Burlington, Massachusetts.LeMaitre Vascular NASDAQ:LMAT$101.82 -3.88 (-3.67%) Closing price 04:00 PM EasternExtended Trading$101.90 +0.08 (+0.07%) As of 05:06 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.LeMaitre Vascular, Inc. develops, manufactures, and markets medical devices and implants used in the field of vascular surgery worldwide. It offers human cadaver tissue cryopreservation services; angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude the blood flow; and perfusion catheters to perfuse the blood and other fluids into the vasculature. The company also provides artegraft biologic graft, a bovine carotid artery used for dialysis access; XenoSure biologic patches, used for closure of vessels after surgical intervention; VascuCel and CardioCel biologic patches, used in vessel repair, heart repair and reconstruction, and neonatal repairs; cardiovascular patches; carotid shunts that temporarily shunt the blood to the brain during the removal of plaque in a carotid endarterectomy surgery; biosynthetic vascular graft indicated for lower extremity bypass and dialysis access; and vascular grafts used to bypass or replace diseased arteries. In addition, it offers radiopaque tape, a medical-grade tape applied to the skin that enables surgeons and interventionalists to cross-refer between the inside and the outside of a patient's body and allows them to locate tributaries or lesions beneath the skin. Further, the company provides valvulotomes, which cut or disrupt valves in the saphenous vein to function as an artery to carry blood past diseased arteries to the lower leg or the foot; and closure systems to attach vessels to one another with titanium clips instead of sutures. It markets its products through a direct sales force and distributors. The company was formerly known as Vascutech, Inc. and changed its name to LeMaitre Vascular, Inc. in April 2001. LeMaitre Vascular, Inc. was incorporated in 1983 and is headquartered in Burlington, Massachusetts.MiMedx Group NASDAQ:MDXG$4.26 +0.06 (+1.43%) Closing price 04:00 PM EasternExtended Trading$4.24 -0.02 (-0.49%) As of 07:26 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins. The company's patented and proprietary processing method employs aseptic processing techniques in addition to terminal sterilization. Its products include EpiFix, a barrier membrane allograft used for the treatment of chronic wounds, including diabetic foot ulcers, venous leg ulcers, and pressure ulcers; AmnioFix, a protective barrier allograft, which comprises dehydrated human amnion/chorion membrane for use in surgical recovery applications; and EpiCord and AmnioCord are dehydrated human umbilical cord allografts that are used to provide a protective environment for the healing process, as well as used in the advanced wound care and surgical recovery applications. The company's products have applications in the areas of wound care, burn, surgical sectors of healthcare. The company sells its products through direct sales force and independent sales agents, as well as through independent distributors primarily in the United States. MiMedx Group, Inc. was founded in 2006 and is headquartered in Marietta, Georgia.Pulse Biosciences NASDAQ:PLSE$28.11 +0.08 (+0.29%) Closing price 04:00 PM EasternExtended Trading$28.04 -0.06 (-0.23%) As of 07:31 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Why Exxon Could Be the Market's Next Big Comeback Stock Why Penguin Solutions May Be the Smartest AI Infrastructure Stock The Market Just Got Shaken—These 3 ETFs May Come Out Stronger Meta Platforms’ Cloud Push: Growth Opportunity Versus AI Concerns A Market Panic Just Discounted the AI Highway's Tollbooth Vertex’s Crinetics Deal Balances Growth with Integration Risk Apple and Broadcom Forge a Decade-Long Silicon Fortress These 3 Cash-Flow Stocks Give Investors More Than Just Growth Potential Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
